NM_006031.6:c.7130C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006031.6(PCNT):​c.7130C>T​(p.Pro2377Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0526 in 1,613,866 control chromosomes in the GnomAD database, including 2,622 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P2377P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.041 ( 195 hom., cov: 33)
Exomes 𝑓: 0.054 ( 2427 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.50

Publications

18 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017070472).
BP6
Variant 21-46422075-C-T is Benign according to our data. Variant chr21-46422075-C-T is described in ClinVar as Benign. ClinVar VariationId is 138631.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0609 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006031.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCNT
NM_006031.6
MANE Select
c.7130C>Tp.Pro2377Leu
missense
Exon 32 of 47NP_006022.3
PCNT
NM_001315529.2
c.6776C>Tp.Pro2259Leu
missense
Exon 32 of 47NP_001302458.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCNT
ENST00000359568.10
TSL:1 MANE Select
c.7130C>Tp.Pro2377Leu
missense
Exon 32 of 47ENSP00000352572.5
PCNT
ENST00000480896.5
TSL:1
c.6776C>Tp.Pro2259Leu
missense
Exon 32 of 47ENSP00000511989.1
PCNT
ENST00000695558.1
c.7163C>Tp.Pro2388Leu
missense
Exon 33 of 48ENSP00000512015.1

Frequencies

GnomAD3 genomes
AF:
0.0415
AC:
6311
AN:
152194
Hom.:
196
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00982
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0261
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00911
Gnomad FIN
AF:
0.0851
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0625
Gnomad OTH
AF:
0.0382
GnomAD2 exomes
AF:
0.0431
AC:
10807
AN:
251014
AF XY:
0.0430
show subpopulations
Gnomad AFR exome
AF:
0.00857
Gnomad AMR exome
AF:
0.0180
Gnomad ASJ exome
AF:
0.0570
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0864
Gnomad NFE exome
AF:
0.0608
Gnomad OTH exome
AF:
0.0464
GnomAD4 exome
AF:
0.0538
AC:
78595
AN:
1461554
Hom.:
2427
Cov.:
32
AF XY:
0.0528
AC XY:
38378
AN XY:
727076
show subpopulations
African (AFR)
AF:
0.00777
AC:
260
AN:
33480
American (AMR)
AF:
0.0198
AC:
884
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0554
AC:
1447
AN:
26134
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39700
South Asian (SAS)
AF:
0.0135
AC:
1168
AN:
86258
European-Finnish (FIN)
AF:
0.0834
AC:
4436
AN:
53160
Middle Eastern (MID)
AF:
0.0243
AC:
140
AN:
5768
European-Non Finnish (NFE)
AF:
0.0606
AC:
67396
AN:
1111940
Other (OTH)
AF:
0.0473
AC:
2858
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
4294
8588
12883
17177
21471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2426
4852
7278
9704
12130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0414
AC:
6309
AN:
152312
Hom.:
195
Cov.:
33
AF XY:
0.0408
AC XY:
3042
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00979
AC:
407
AN:
41586
American (AMR)
AF:
0.0261
AC:
399
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00932
AC:
45
AN:
4828
European-Finnish (FIN)
AF:
0.0851
AC:
903
AN:
10610
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0625
AC:
4250
AN:
68016
Other (OTH)
AF:
0.0378
AC:
80
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
306
613
919
1226
1532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0501
Hom.:
391
Bravo
AF:
0.0360
TwinsUK
AF:
0.0537
AC:
199
ALSPAC
AF:
0.0597
AC:
230
ESP6500AA
AF:
0.0138
AC:
61
ESP6500EA
AF:
0.0609
AC:
524
ExAC
AF:
0.0433
AC:
5263
Asia WGS
AF:
0.0100
AC:
35
AN:
3478
EpiCase
AF:
0.0541
EpiControl
AF:
0.0536

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 31, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Microcephalic osteodysplastic primordial dwarfism type II Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.085
DANN
Benign
0.63
DEOGEN2
Benign
0.027
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0091
N
LIST_S2
Benign
0.48
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.2
L
PhyloP100
-1.5
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.086
Sift
Benign
0.23
T
Sift4G
Benign
0.13
T
Polyphen
0.76
P
Vest4
0.031
MPC
0.41
ClinPred
0.012
T
GERP RS
-7.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.011
gMVP
0.094
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735814; hg19: chr21-47841989; COSMIC: COSV64027462; COSMIC: COSV64027462; API